As tenders become an increasingly important commercial lever for pharmaceutical companies, AI and new technologies are raising expectations around speed, consistency, and decision quality. Yet many organizations still lack the strategic foundations needed to unlock their full potential.
Watch our recording to explore exclusive insights from Simon-Kucher’s 2026 Tender Excellence industry study and interviews with industry leaders across Europe and Asia. Our experts discuss how leading pharma companies are building more strategic and scalable tender capabilities and where AI can create real value.
Participants will learn:
- How procurement trends are reshaping tender management
- Where AI and automation can create tangible value
- Which foundations are critical for technology and AI to deliver impact
- How to prioritize investments across processes, data, systems, and AI
